Skip to content
knowrare
HealthSignal
Your condition community

Living with STT3A-congenital disorder of glycosylation

An inherited condition with delayed development, low muscle tone, seizures, and slow weight gain.

Understanding STT3A-congenital disorder of glycosylation

STT3A-congenital disorder of glycosylation (STT3A-CDG) is an inherited condition that mainly affects development and the nervous system.

Children have delayed development and intellectual disability, slow weight gain, low muscle tone, and seizures. Feeding problems are common, and some have a small head. Some boys have genital differences such as undescended testes. Signs may begin in the newborn or infant years.

Signs & symptoms

Symptoms vary from person to person. GARD lists these among the most common:

  • Delayed development
  • Intellectual disability
  • Low muscle tone
  • Seizures
  • Feeding trouble and slow weight gain
  • Small head (microcephaly)

Not everyone has every symptom. GARD's list comes from the Human Phenotype Ontology.

Diagnosis

  1. Talk with your doctor

    Share the symptoms you've noticed, when they started and your family health history. Notes and photos can help.

  2. See a specialist

    Specialists who may be involved include brain and nervous system specialists, genetic specialists and seizure and epilepsy specialists.

  3. Consider genetic testing

    Changes in STT3A are linked to this condition. Genetic testing and counseling can help confirm a diagnosis and explain what it means for your family.

  4. Connect with expert centers

    Epilepsy Foundation may keep lists of experts for this condition.

Care & treatment

Care team
Brain and nervous system specialists (neurologists); Genetic specialists (geneticists); Seizure and epilepsy specialists (epileptologist)
Expert care
Expert lists: Epilepsy Foundation
Treatment
GARD doesn't list specific treatments for this condition. Your care team will tailor care to your symptoms.
Research
Clinical trials and observational studies may be options. See the research section below.

General information, not medical advice. Your care team makes the decisions.

Everyday life

Living with a rare condition is easier with support.

  • Connect with Epilepsy Foundation
  • Keep notes on symptoms, changes and questions for appointments
  • Ask about patient registries that help research
  • Look into financial aid and travel resources for care visits
Bring these questions to your next doctor visit
What feeding support could help my child?
How can we manage seizures, if they occur?
Would STT3A gene testing help our family?

Quick facts

Symptoms usually startNewborn and as an Infant
InheritanceAutosomal Recessive
GenesSTT3A

Changes in the STT3A gene cause this condition. It is autosomal recessive, meaning a child inherits a changed copy of the gene from each parent.

GeneticNeurologicalInherited Metabolic

Also known as: cdg syndrome type iw; cdg-iw; cdg1w; congenital disorder of glycosylation type 1w; congenital disorder of glycosylation type iw; congenital disorder of glycosylation, type iw, autosomal recessive

Patient organizations

Broader rare-disease groups

Source: NIH GARD · STT3A-congenital disorder of glycosylationGARD ID 17602 · GARD page updated September 2026 · Plain-language summary by Know Rare; editorial review pending. General information, not medical advice.

You are more than your diagnosis

Perspectives from people navigating life with STT3A-congenital disorder of glycosylation.

Explore the STT3A-congenital disorder of glycosylation blog

Explore research for STT3A-congenital disorder of glycosylation

Explore actively recruiting STT3A-congenital disorder of glycosylation studies with HealthSpark.

HealthSpark

Find actively recruiting studies for STT3A-congenital disorder of glycosylation with HealthSpark. Share your city to explore research near you.

  • Recruiting studies from ClinicalTrials.gov
  • Share your city to look for research near you
  • Eligibility is confirmed by the study team

Powered by HealthSpark, our AI chat helper

I can help you find recruiting STT3A-congenital disorder of glycosylation studies. Enter a ZIP code, address or city below and I'll look within 50 miles.

Powered by HealthSpark, our AI chat helper · Study information from ClinicalTrials.gov · Eligibility is confirmed by the study team.

Get Signals for STT3A-congenital disorder of glycosylation

Stay in the loop with community stories and updates from medical researchers.

HealthStoryfor STT3A-congenital disorder of glycosylation

Create a living journal that talks back

HealthStory evolves private journaling with a living AI journal that talks back and asks thoughtful questions, helping you capture your STT3A-congenital disorder of glycosylation experiences more deeply and prepare for better conversations with your doctors and care team.

Start your journal

Your journal is private. Sharing your story publicly is a separate choice, made with Share your story above.